cilostazol has been researched along with A-V Dissociation in 3 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Treatment with cilostazol significantly decreased the concentration of plasma atrial natriuretic peptide from 88 pg/mL (95% CI, 49 to 160 pg/mL) to 51 pg/mL (95% CI, 32 to 80 pg/mL; p = 0." | 1.32 | Effect of cilostazol on the ventricular escape rate and neurohumoral factors in patients with third-degree atrioventricular block. ( Iwata, T; Kodama-Takahashi, K; Kurata, A; Ohshima, K; Uemura, S; Watanabe, S; Yamamoto, K, 2003) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Madias, JE | 1 |
| Kodama-Takahashi, K | 1 |
| Kurata, A | 1 |
| Ohshima, K | 1 |
| Yamamoto, K | 1 |
| Uemura, S | 1 |
| Watanabe, S | 1 |
| Iwata, T | 1 |
| Atarashi, H | 1 |
| Endoh, Y | 1 |
| Saitoh, H | 1 |
| Kishida, H | 1 |
| Hayakawa, H | 1 |
1 trial available for cilostazol and A-V Dissociation
| Article | Year |
|---|---|
Chronotropic effects of cilostazol, a new antithrombotic agent, in patients with bradyarrhythmias.
Topics: Administration, Oral; Aged; Aged, 80 and over; Arrhythmias, Cardiac; Atrial Fibrillation; Bradycardi | 1998 |
2 other studies available for cilostazol and A-V Dissociation
| Article | Year |
|---|---|
Cilostazol: an "intermittent claudication" remedy for the management of third-degree AV block.
Topics: Cilostazol; Heart Block; Heart Conduction System; Humans; Platelet Aggregation Inhibitors; Tetrazole | 2003 |
Effect of cilostazol on the ventricular escape rate and neurohumoral factors in patients with third-degree atrioventricular block.
Topics: Aged; Aged, 80 and over; Atrial Natriuretic Factor; Cilostazol; Electrocardiography; Female; Heart B | 2003 |